[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20014383L - Fremgangsmåte for fremstilling av syklo-(Asp-DPhe-NMeVal-Arg- Gly) - Google Patents

Fremgangsmåte for fremstilling av syklo-(Asp-DPhe-NMeVal-Arg- Gly)

Info

Publication number
NO20014383L
NO20014383L NO20014383A NO20014383A NO20014383L NO 20014383 L NO20014383 L NO 20014383L NO 20014383 A NO20014383 A NO 20014383A NO 20014383 A NO20014383 A NO 20014383A NO 20014383 L NO20014383 L NO 20014383L
Authority
NO
Norway
Prior art keywords
nmeval
dphe
cyclo
gly
asp
Prior art date
Application number
NO20014383A
Other languages
English (en)
Other versions
NO330030B1 (no
NO20014383D0 (no
Inventor
Alfred Jonczyk
Markus Arnold
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20014383D0 publication Critical patent/NO20014383D0/no
Publication of NO20014383L publication Critical patent/NO20014383L/no
Publication of NO330030B1 publication Critical patent/NO330030B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • C07K5/06095Arg-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0819Tripeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20014383A 1999-03-11 2001-09-10 Fremgangsmate for fremstilling av syklo(Arg-Gly-Asp-DPhe-NMeVal), samt rettkjedede pentapeptider som mellomprodukter i syntesen av syklo(Arg-Gly-Asp-DPhe-NMeVal). NO330030B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19910727 1999-03-11
PCT/EP2000/001751 WO2000053627A1 (de) 1999-03-11 2000-03-01 VERFAHREN ZUR HERSTELLUNG VON CYCLO-(Asp-DPhe-NMeVal-Arg-Gly)

Publications (3)

Publication Number Publication Date
NO20014383D0 NO20014383D0 (no) 2001-09-10
NO20014383L true NO20014383L (no) 2001-11-02
NO330030B1 NO330030B1 (no) 2011-02-07

Family

ID=7900511

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014383A NO330030B1 (no) 1999-03-11 2001-09-10 Fremgangsmate for fremstilling av syklo(Arg-Gly-Asp-DPhe-NMeVal), samt rettkjedede pentapeptider som mellomprodukter i syntesen av syklo(Arg-Gly-Asp-DPhe-NMeVal).

Country Status (28)

Country Link
US (1) US6822074B1 (no)
EP (1) EP1159296B1 (no)
JP (1) JP4762418B2 (no)
KR (1) KR100645002B1 (no)
CN (1) CN1200947C (no)
AR (1) AR022905A1 (no)
AT (1) ATE267839T1 (no)
AU (1) AU762540B2 (no)
BR (1) BR0008863A (no)
CA (1) CA2366694C (no)
CZ (1) CZ299879B6 (no)
DE (1) DE50006598D1 (no)
DK (1) DK1159296T3 (no)
ES (1) ES2221616T3 (no)
HK (1) HK1044780B (no)
HU (1) HUP0200369A3 (no)
ID (1) ID30126A (no)
MY (1) MY120083A (no)
NO (1) NO330030B1 (no)
PL (1) PL202996B1 (no)
PT (1) PT1159296E (no)
RU (1) RU2243974C2 (no)
SE (1) SE1159296T5 (no)
SK (1) SK285387B6 (no)
TW (1) TWI269798B (no)
UA (1) UA71608C2 (no)
WO (1) WO2000053627A1 (no)
ZA (1) ZA200108335B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0814519D0 (en) 2008-08-08 2008-09-17 Imp Innovations Ltd Process
US20120058905A1 (en) * 2009-05-15 2012-03-08 Covello Patrick S DNA Sequences Encoding Caryophyllaceae and Caryophyllaceae-Like Cyclopeptide Precursors and Methods of Use
US8586545B2 (en) * 2009-05-20 2013-11-19 Merck Patent Gmbh Solid materials of {[(2S, 5R,8S,11S)-5-benzyl-11-(3-guanidino-propyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acid} and methods for obtaining them
WO2011069629A2 (en) 2009-12-10 2011-06-16 Merck Patent Gmbh Pharmaceutical composition comprising oligopeptides
EP2717854B1 (en) 2011-06-09 2019-01-16 Merck Patent GmbH Treatment of cancers and metastases with suspensions of cilengitide in carrier
US11753440B2 (en) * 2018-06-05 2023-09-12 Dsm Ip Assets B.V. Methods for the synthesis of arginine-containing peptides

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1038741B (de) * 1956-09-14 1958-09-11 Eberhard Brecklinghaus Aus Gummi oder einem anderen elastischen Werkstoff bestehender Kantenschoner fuer Treppenstufen aus Beton od. dgl.
US3630660A (en) * 1968-10-31 1971-12-28 Burlington Industries Inc Process for removal of moisture and/or solvents from textile materials
UA43823C2 (uk) * 1992-07-06 2002-01-15 Мерк Патент Геселлшафт Міт Бесшренктер Хафтунг ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ДЛЯ ІНГІБУВАННЯ ІНТЕГРИН <font face="Symbol">a</font><sub>V</sub><font face="Symbol">b</font><sub>3</sub>-ОПОСЕРЕДКОВАНОЇ КЛІТИННОЇ АДГЕЗІЇ КЛІТИН ССАВЦІВ, СПОСІБ ЛІКУВАННЯ ТА ПРОФІЛАКТИКИ ЗАХВОРЮВАННЯ, АСОЦІЙОВАНОГО З ПОРУШЕННЯМ АДГЕЗІЇ КЛІТИН, СПОСІБ БЛОКУВАННЯ ЗВ'ЯЗУВАННЯ ФІБРИНОГЕНОМ ІНТЕГРИНУ, КОМПОЗИЦІЯ ДЛЯ ЗАГОЄННЯ РАН
JPH06263798A (ja) * 1993-01-13 1994-09-20 Takeda Chem Ind Ltd βターン及びγターンを有する環状ペンタペプチド、その製造方法および用途
EP0953573A3 (en) * 1993-01-13 1999-12-29 Takeda Chemical Industries, Ltd. Pentapeptide with specific conformation, its production and use
DE4310643A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
ATE226960T1 (de) * 1994-06-02 2002-11-15 Forssmann Wolf Georg Verfahren zur herstellung von cardiodilatin- fragmenten, hochgereinigte cardiodilatin- fragmente und zwischenprodukte zu deren herstellung
DE19534177A1 (de) * 1995-09-15 1997-03-20 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
DE19538741A1 (de) 1995-10-18 1997-04-24 Merck Patent Gmbh Cyclopeptidderivate
DE19613933A1 (de) 1996-04-06 1997-10-09 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
EP0951295B1 (en) * 1996-05-31 2010-06-09 The Scripps Research Institute Compositions for use in inhibiting of alpha-v-beta3 mediated angiogenesis
DE19728524A1 (de) * 1997-07-04 1999-01-07 Merck Patent Gmbh Cyclische Azapeptide

Also Published As

Publication number Publication date
RU2243974C2 (ru) 2005-01-10
SE1159296T5 (no) 2004-09-07
DE50006598D1 (de) 2004-07-01
ZA200108335B (en) 2003-01-10
SK12552001A3 (sk) 2002-05-09
CN1200947C (zh) 2005-05-11
JP2002539137A (ja) 2002-11-19
CZ299879B6 (cs) 2008-12-17
TWI269798B (en) 2007-01-01
CA2366694C (en) 2010-07-20
SK285387B6 (sk) 2006-12-07
KR20010102503A (ko) 2001-11-15
UA71608C2 (en) 2004-12-15
HUP0200369A3 (en) 2002-09-30
AU762540B2 (en) 2003-06-26
NO330030B1 (no) 2011-02-07
HUP0200369A2 (en) 2002-06-29
BR0008863A (pt) 2002-01-02
ID30126A (id) 2001-11-08
HK1044780A1 (en) 2002-11-01
NO20014383D0 (no) 2001-09-10
ES2221616T3 (es) 2005-01-01
CN1343220A (zh) 2002-04-03
DK1159296T3 (da) 2004-09-27
AR022905A1 (es) 2002-09-04
WO2000053627A1 (de) 2000-09-14
HK1044780B (zh) 2005-08-26
EP1159296A1 (de) 2001-12-05
PL202996B1 (pl) 2009-08-31
ATE267839T1 (de) 2004-06-15
PT1159296E (pt) 2004-10-29
US6822074B1 (en) 2004-11-23
KR100645002B1 (ko) 2006-11-10
EP1159296B1 (de) 2004-05-26
JP4762418B2 (ja) 2011-08-31
AU4103400A (en) 2000-09-28
MY120083A (en) 2005-08-30
SE1159296T3 (no) 2004-08-24
CA2366694A1 (en) 2000-09-14
CZ20013214A3 (cs) 2001-12-12

Similar Documents

Publication Publication Date Title
NO20015017D0 (no) Fremgangsmåte for fremstilling av citalopram
NO20010318D0 (no) Fremgangsmåte for fremstilling av Citalopram
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
NO20010319L (no) Fremgangsmate for fremstilling av Citalopram
NO20006039L (no) Fremgangsmåte for fremstilling av 4-karboksyamino-2- substituert-1,2,3,4- tetrahydroquinolin
EE04747B1 (et) Amiini-plaatina komplekside valmistamismeetod
NO20005000D0 (no) FremgangsmÕte for fremstilling av rÕstoffer for glassfremstilling
NO20042640L (no) Fremgangsmate for fremstilling av ekinocandinderivater
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
NO20014383D0 (no) Fremgangsmåte for fremstilling av syklo-(Asp-DPhe-NMeVal-Arg- Gly)
NO20020059L (no) Fremgangsmåte for fremstilling av dibenzotiazepinderivater
IL149534A0 (en) Preparation of 3-substituted-4-arylquinolin-2-one derivatives
GB2363605B (en) Process for the preparation of alpha-aminoketone derivatives
NO20013407L (no) Fremgangsmate for fremstilling av kinolinkarbaldehyd
NO20013995L (no) Fremgangsmåte for fremstilling av L-sorbose
NO20000805L (no) FremgangsmÕte for fremstilling av organiske azider
NO20022956D0 (no) Fremgangsmåte for fremstilling av nitroguanidin
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
NO20012811D0 (no) Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
NO20013044D0 (no) Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
NO20005818D0 (no) Forbedret fremgangsmåte for fremstilling av farmasöytisk verdifulle norbenzomorfan-derivater
EE200200053A (et) Isoretinoiini valmistamise protsess
NO20016271D0 (no) Fremgangsmåte for fremstilling av substituerte [1,4]diazepino[6,7,1-hi]indol-4-oner
NO20002558D0 (no) FremgangsmÕte for fremstilling av findisperse eksplosivstoffer

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees